ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,187.40
      0.13%
      US Tech 100
      17,646.80
      0.21%
      Dow Jones
      38,879.08
      0.07%
      Brent Oil
      83.265
      -0.25%
      Bitcoin
      63,322.30
      0.25%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aptose Biosciences Inc (APTO)

      7. Aptose Biosciences Inc (APTO) News

      APTO

      Aptose Biosciences (APTO)

      Aptose Biosciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:APTO
      DateTimeSourceHeadlineSymbolCompany
      12:51PMiHub NewswireFeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa
      05/06/20244:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
      03/01/20245:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
      02/14/20244:51PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APTOAptose Biosciences Inc
      02/07/20246:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      02/07/20245:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      02/07/20245:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      02/07/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      02/07/20245:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      02/07/20244:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      02/07/20244:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      02/07/20244:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      02/07/20244:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      02/07/20244:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      02/07/20244:33PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
      01/31/20244:02PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
      01/26/20245:30PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:APTOAptose Biosciences Inc
      01/26/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
      01/26/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:APTOAptose Biosciences Inc
      01/25/20249:44PMEdgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:APTOAptose Biosciences Inc
      01/19/20249:50PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APTOAptose Biosciences Inc
      12/29/20234:10PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APTOAptose Biosciences Inc
      12/11/20236:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
      12/11/20236:15AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:APTOAptose Biosciences Inc
      11/30/20235:28PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
      11/09/20235:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APTOAptose Biosciences Inc
      11/02/20239:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
      10/30/20239:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
      10/26/202310:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
      10/23/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
       Showing the most relevant articles for your search:NASDAQ:APTO